Aimmune Therapeutics, Inc.
Pharmaceutical company · Brisbane, California, United States
Aimmune Therapeutics, Inc. is a pharmaceutical company headquartered in Brisbane, California, United States. Its earliest recorded incorporation is in 2011. It has reported private securities offerings to the US SEC, most recently $98 million sold in a notice filed in 2018.
Aimmune Therapeutics at a glance
What does Aimmune Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $98 million sold (2018).
Frequently asked questions about Aimmune Therapeutics
Where is Aimmune Therapeutics headquartered?
Aimmune Therapeutics, Inc. is headquartered in Brisbane, California, United States.
What does Aimmune Therapeutics do?
Aimmune Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Aimmune Therapeutics founded?
The earliest incorporation on record for Aimmune Therapeutics, Inc. is in 2011, according to public company registers.
Similar companies
- Annexon, Inc.Brisbane, California, United States
- Day One Biopharmaceuticals, Inc.Brisbane, California, United States
- Vera Therapeutics, Inc.Brisbane, California, United States
- Tempest Therapeutics, Inc.Brisbane, California, United States
- MyoKardia, Inc.Brisbane, California, United States
- Nurix Therapeutics, Inc.Brisbane, California, United States
- Dance Biopharm Inc.Brisbane, California, United States
- Intermune IncBrisbane, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences